Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 2.60%263.6B | 4.65%1.08T | 2.39%256.93B | 1.00%1.03T | 1.63%243.33B | -5.34%279.99B | 1.51%256.43B | 7.87%250.92B | 17.74%1.02T | 16.53%239.44B |
| Cost of revenue | 1.73%225.1B | 4.03%933.03B | 2.03%221.27B | 1.32%896.86B | 1.66%214.52B | -4.89%244.61B | 1.19%220.87B | 9.13%216.86B | 18.63%885.2B | 17.33%211.01B |
| Gross profit | 7.96%38.49B | 8.80%145.6B | 4.69%35.66B | -1.06%133.82B | 1.38%28.81B | -8.30%35.38B | 3.52%35.56B | 0.48%34.06B | 12.25%135.25B | 10.84%28.42B |
| Operating expense | 3.81%29.07B | 7.39%115.22B | 6.17%28B | 1.52%107.28B | 7.15%27.64B | -2.85%26.78B | 0.76%26.49B | 1.34%26.37B | 9.31%105.68B | 6.60%25.79B |
| Operating profit | 23.13%9.43B | 14.50%30.38B | -0.38%7.66B | -10.29%26.53B | -55.25%1.18B | -21.92%8.6B | 12.50%9.07B | -2.34%7.69B | 24.17%29.58B | 81.87%2.63B |
| Net non-operating interest income (expenses) | -3.80%-984M | -21.45%-4.2B | -37.19%-948M | -51.42%-3.45B | -36.54%-964M | -43.33%-946M | -64.67%-853M | -74.06%-691M | -62.70%-2.28B | -119.94%-706M |
| Non-operating interest expense | 3.80%984M | 21.45%4.2B | 37.19%948M | 51.42%3.45B | 36.54%964M | 43.33%946M | 64.67%853M | 74.06%691M | 62.70%2.28B | 119.94%706M |
| Net investment income | -95.25%99M | -26.20%3.27B | -9.71%2.08B | 32.65%4.43B | 17.14%950M | 104.07%84M | -12.59%1.09B | -31.04%2.31B | 102.61%3.34B | -54.46%811M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 1.82B | 1,437.80%10.9B | 0 | 456.28%709M | 14,928.57%1.05B | 1,725.00%73M | -182.26%-51M | -34.19%-365M | -190.45%-199M | -96.80%7M |
| Income from associates and other participating interests | -70.18%99M | -162.92%-224M | -66.43%332M | -68.01%356M | -398.36%-1.22B | 1.23%741M | -125.71%-158M | 42.30%989M | 37.75%1.11B | 34.58%-244M |
| Special income (charges) | -20.69%-35M | -129.74%-1.21B | 81.88%-29M | 332.29%4.08B | -1.54%-1.65B | 2,744.30%8.36B | -1,674.10%-2.47B | -149.23%-160M | -447.04%-1.76B | -579.65%-1.63B |
| Less:Restructuring and mergern&acquisition | ---- | ---- | ---- | --0 | --0 | ---- | ---- | --0 | -286.59%-317M | ---1M |
| Less:Other special charges | 20.69%35M | 98.15%-90M | -81.88%29M | -388.86%-4.88B | 0.56%1.25B | -2,758.54%-8.4B | 1,422.30%2.12B | 1,877.78%160M | 335.10%1.69B | 190.46%1.24B |
| Less:Write off | ---- | 63.49%1.3B | ---- | 107.01%797M | 4.42%402M | --45M | ---- | ---- | -65.66%385M | -62.77%385M |
| Other non-operating income (expenses) | -5.26%702M | -6.58%3.02B | -19.54%741M | 84.96%3.24B | 474.69%931M | 35.23%833M | 76.85%550M | 39.55%921M | -36.24%1.75B | -48.90%162M |
| Income before tax | 13.07%11.12B | 16.87%41.95B | -7.95%9.84B | 13.78%35.89B | -73.14%278M | 90.23%17.74B | -19.79%7.18B | -12.60%10.69B | 14.63%31.55B | -69.65%1.04B |
| Income tax | 32.72%3.01B | 8.51%12.12B | -34.80%2.27B | 58.25%11.17B | 154.17%403M | 114.59%5.16B | 0.57%2.12B | 5.93%3.48B | -1.93%7.06B | -151.06%-744M |
| Net income | 7.18%8.11B | 20.64%29.83B | 5.02%7.57B | 0.96%24.72B | -106.97%-124M | 81.77%12.58B | -26.06%5.06B | -19.43%7.2B | 20.50%24.49B | -8.96%1.78B |
| Net income continuous operations | 7.18%8.11B | 20.64%29.83B | 5.02%7.57B | 0.96%24.72B | -107.03%-125M | 81.77%12.58B | -26.06%5.06B | -19.42%7.21B | 20.50%24.49B | -8.91%1.78B |
| Noncontrolling interests | 56.92%1.61B | 69.60%6.56B | 86.21%1.03B | -34.33%3.87B | -13.64%1.46B | -32.77%1.04B | -40.98%821M | -56.48%551M | 72.12%5.89B | 37.52%1.69B |
| Net income attributable to the company | -0.63%6.5B | 11.56%23.26B | -1.68%6.54B | 12.14%20.85B | -1,800.00%-1.58B | 114.74%11.54B | -22.22%4.24B | -13.33%6.65B | 10.05%18.6B | -87.21%93M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -0.63%6.5B | 11.56%23.26B | -1.68%6.54B | 12.14%20.85B | -1,800.00%-1.58B | 114.74%11.54B | -22.22%4.24B | -13.33%6.65B | 10.05%18.6B | -87.21%93M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -0.65%43.0067 | 11.68%153.9667 | -1.52%43.2867 | 13.73%137.87 | -1,042.60%-10.4 | 114.44%76.29 | -21.66%28.0233 | -9.88%43.9567 | 13.25%121.2267 | -76.03%1.1033 |
| Diluted earnings per share | -0.65%43.0067 | 11.68%153.9667 | -1.52%43.2867 | 13.73%137.87 | -1,802.94%-10.4639 | 115.10%76.29 | -21.66%28.0233 | -9.88%43.9567 | 13.25%121.2267 | -86.65%0.6145 |
| Dividend per share | 0 | 29.41%36.6667 | 0 | 30.77%28.3333 | -23.08%16.6667 | 0 | 11.6667 | 0 | 18.18%21.6667 | 18.18%21.6667 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |